Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries OmniAb, Inc. - Common Stock (NQ: OABI ) 4.190 -0.080 (-1.87%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 427,837 Open 4.260 Bid (Size) 4.160 (3) Ask (Size) 4.230 (2) Prev. Close 4.270 Today's Range 4.160 - 4.280 52wk Range 3.560 - 6.715 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News OmniAb to Participate in Two Investor Conferences in September August 26, 2024 From OmniAb, Inc. Via Business Wire OABI Stock Earnings: OmniAb Beats EPS, Beats Revenue for Q2 2024 August 08, 2024 OABI stock results show that OmniAb beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace Performance YTD -32.96% -32.96% 1 Month -12.53% -12.53% 3 Month -3.46% -3.46% 6 Month -29.10% -29.10% 1 Year -27.76% -27.76% More News Read More OmniAb Reports Second Quarter 2024 Financial Results and Business Highlights August 08, 2024 From OmniAb, Inc. Via Business Wire OmniAb to Report Second Quarter 2024 Financial Results on August 8 July 25, 2024 From OmniAb, Inc. Via Business Wire OmniAb Announces Publication of Scientific Paper on Heavy Chain-Only Single-Domain Antibody Chicken Platform in the Journal of Immunology June 03, 2024 From OmniAb, Inc. Via Business Wire Recap: OmniAb Q4 Earnings March 20, 2024 Via Benzinga Earnings Preview For OmniAb March 19, 2024 Via Benzinga OmniAb to Participate in the Jefferies Global Healthcare Conference May 20, 2024 From OmniAb, Inc. Via Business Wire OmniAb Presents High-Throughput Single B-cell Screening xPloration® Data at the 20th Annual PEGS Boston Summit May 15, 2024 From OmniAb, Inc. Via Business Wire OABI Stock Earnings: OmniAb Misses EPS, Misses Revenue for Q1 2024 May 09, 2024 Via InvestorPlace OmniAb Reports First Quarter 2024 Financial Results and Business Highlights May 09, 2024 From OmniAb, Inc. Via Business Wire OmniAb to Participate in Five Investor Conferences in May May 01, 2024 From OmniAb, Inc. Via Business Wire OmniAb to Report First Quarter 2024 Financial Results on May 9 April 22, 2024 From OmniAb, Inc. Via Business Wire Over $1M Bet On OmniAb? Check Out These 3 Stocks Insiders Are Buying March 26, 2024 Via Benzinga OABI Stock Earnings: OmniAb Beats EPS, Misses Revenue for Q4 2023 March 20, 2024 Via InvestorPlace OmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights March 20, 2024 From OmniAb, Inc. Via Business Wire Earnings Scheduled For March 20, 2024 March 20, 2024 Via Benzinga OmniAb to Report Fourth Quarter 2023 Financial Results on March 20 February 26, 2024 From OmniAb, Inc. Via Business Wire OmniAb to Participate in Two Investor Conferences in March February 20, 2024 From OmniAb, Inc. Via Business Wire Mighty Minis: 7 Small-Cap Stocks That Punch Above Their Weight December 15, 2023 Via InvestorPlace OmniAb Presents New Scientific Data on its OmnidAb™ Platform at the 2023 Antibody Engineering & Therapeutics Conference December 14, 2023 From OmniAb, Inc. Via Business Wire OmniAb Highlights OmnidAb™ Launch and its Expanding Drug Discovery Platform at Today’s Research & Technology Virtual Event November 09, 2023 From OmniAb, Inc. Via Business Wire OmniAb Reports Third Quarter 2023 Financial Results and Business Highlights November 09, 2023 From OmniAb, Inc. Via Business Wire OmniAb to Participate in Two Investor Conferences in November November 02, 2023 From OmniAb, Inc. Via Business Wire OmniAb Appoints Steve Love to its Board of Directors November 01, 2023 From OmniAb, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
